| 评TACTICS试验：TACE联合索拉非尼与单纯TACE在不可切除肝细胞癌中的对比研究 |
| |
| 引用本文： | 陈双刚,范卫君,杨翼帆.评TACTICS试验：TACE联合索拉非尼与单纯TACE在不可切除肝细胞癌中的对比研究[J].循证医学,2022,21(6):332-336. |
| |
| 作者姓名： | 陈双刚 范卫君 杨翼帆 |
| |
| 作者单位： | 1.汕头大学附属粤北人民医院肿瘤内科, 广东韶关512028;2.中山大学肿瘤防治中心微创介入治疗科, 广州 510060;3.广东省人民医院综合（介入）肿瘤一科, 广州 510080 |
| |
| 摘 要： |
|
Comment on the TACTICS Trial： A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma |
| |
| CHEN Shuang-gang,FAN Wei-jun,YANG Yi-fan.Comment on the TACTICS Trial： A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma[J].The Journal of Evidence-Based Medicine,2022,21(6):332-336. |
| |
| Authors: | CHEN Shuang-gang FAN Wei-jun YANG Yi-fan |
| |
| Institution: | Reviewers'address： 1. Department of Oncology, Yuebei People's Hospital, Shantou University Medical College, Guangdong Shaoguan 512028, China;
2. Minimally Invasive Interventional Division, Sun Yat-sen University Cancer Center, Guangzhou 510060, China |
| |
| Abstract: | |
| |
| Keywords: | |
|
| 点击此处可从《循证医学》浏览原始摘要信息 |
| 点击此处可从《循证医学》下载免费的PDF全文 |
|
